In this study, we demonstrate elevated expression levels of SDC2 and FN in plasma-derived MV-enriched EVs isolated from neoadjuvant chemotherapy-naïve obese breast cancer patients with pLNM compared to those patients with nLNM. This evidence concerns the gene SDC2 and breast cancer.